
Medical scientific liaisons (MSLs)—the people physicians talk to when they have scientific questions—have traditionally been separated from the marketing and commercial functions. Should the boundaries between the two functions be broken down?
(Sep 1, 2011)Phil Taylor explores how reps can shift their sales strategies from traditional detailing to Key Account Management
(Oct 5, 2011)Traditional sales reps can still play vital roles in the transition to KAM. Phil Taylor reports
(Oct 5, 2011)Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
(Jan 17, 2012)Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
(Feb 1, 2012)Phil Taylor explores the new sales and marketing strategies suggested by a recent Booz & Co-sponsored survey of the pharma sector
(Apr 15, 2012)An audience of more than 150 senior industry professionals will be witness to this meeting of minds, marking the beginning of the two day event at the Regents Park Marriott Hotel in London.
Andrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs